Department of Ophthalmology and Vision Sciences, The Hospital for Sick Children, 555 University Ave, Toronto, Ontario, Canada M5G 2M9.
Br J Ophthalmol. 2013 Jan;97(1):59-65. doi: 10.1136/bjophthalmol-2012-302133. Epub 2012 Oct 26.
Hand-held spectral domain optical coherence tomography (HHSD OCT) has greatly expanded the imaging/diagnostic capacity for clinicians managing children with intraocular retinoblastoma. We present our early experience with HHSD OCT and conventional spectral domain OCT imaging in these patients.
In this retrospective cross-sectional observational study, infants were imaged during examination under anaesthesia with HHSD OCT in the supine position. Older cooperative retinoblastoma patients were additionally imaged with upright conventional OCT. Clinical data were derived from patient charts and from a prospectively maintained interinstitutional retinoblastoma database. Complementary imaging techniques, including RetCam™, fluorescein angiography and B-scan ultrasound, were assessed.
Twenty-two intraocular lesions in 16 patients were imaged. HHSD OCT was used exclusively in 19 lesions, while conventional OCT was also performed in three cases. Small lesions were imaged in five cases, all of which were localised to the middle retinal layers. Clinical uses for HHSD OCT imaging identified included: diagnosis of new lesions, monitoring response to laser therapy and the identification of edge recurrences.
Although indirect ophthalmoscopy remains the gold standard for diagnosis and treatment of retinoblastoma, HHSD OCT is a valuable tool in better understanding and managing retinoblastoma.
手持谱域光学相干断层扫描(HHSD OCT)极大地扩展了临床医生管理眼内视网膜母细胞瘤患儿的成像/诊断能力。我们在此介绍我们在这些患者中使用 HHSD OCT 和传统谱域 OCT 成像的早期经验。
在这项回顾性横断面观察研究中,在全身麻醉下对仰卧位婴儿进行 HHSD OCT 成像。对年龄较大的合作型视网膜母细胞瘤患者还进行直立式传统 OCT 成像。临床数据来自患者图表和一个前瞻性维护的机构间视网膜母细胞瘤数据库。评估了互补的成像技术,包括 RetCam™、荧光素血管造影和 B 型超声。
16 名患者的 22 个眼内病变得到了成像。19 个病变仅使用 HHSD OCT 进行成像,而另外 3 个病变则同时进行了传统 OCT 成像。在 5 个小病变中均定位在中视网膜层。HHSD OCT 成像的临床用途包括:诊断新病变、监测激光治疗的反应以及识别边缘复发。
尽管间接检眼镜仍然是视网膜母细胞瘤诊断和治疗的金标准,但 HHSD OCT 是更好地理解和管理视网膜母细胞瘤的有价值的工具。